Eris Lifesciences Ltd
Praveen Veeramalla is an experienced quality management professional with a substantial background in the pharmaceutical industry. Currently serving as the Vice President & Head of Quality at ERIS Lifesciences since April 2025, Praveen has previously held significant roles such as Global Head Quality/Head Corporate Quality at Shalina Healthcare and General Manager Corporate Quality at SUN PHARMA, focusing on quality compliance and due diligence. Additional experience includes leading corporate quality audit functions at Sanofi and managing quality assurance at Teva Pharmaceuticals and Polpharma. Praveen possesses a Master's degree in Microbiology, a diploma in Quality Assurance and Quality Control Management, and a Bachelor of Science from Kakatiya University. Furthermore, completion of the Global Leadership Program at the Indian School of Business has augmented leadership capabilities.
This person is not in any teams
This person is not in any offices
Eris Lifesciences Ltd
Eris Lifesciences Limited is an India-based company, which is engaged in manufacturing, marketing and selling of generics within the chronic and acute categories of the Indian Pharmaceutical Market. The Company operates within various areas through its seven focused divisions: Eris, Nikkos, Adura, Montana, Inspira, Victus, Eris Kinedex, Eterna, and Altiza. Its Eris division includes Atorsave 10, Atorsave 20, Decal, Enoxsave 0.6 and Metaloc XL100 products; its Nikkos division includes Alerfix, Erinac D, Ezeepam Plus 5, Zenpride OD and Nikotriol products; its Adura division includes Crevast 5, Glitaris M30, Metafort G1 CP and Olmin 10 products; its Montana division includes Meftaris, Calshine 60K Sachet, Hinder, Rabemon 20 and Vomisave Syrup products; its Inspira division includes Crevast F 5, Lnbeta 5 and Twichek products, and its Victus division includes Atorsave D80, Cyblex M 30 XR, Cyblex M 80, Cyblex M 60 XR and Cyblex MV 40.3 products.